Elham Hedayati

Elham Hedayati is an Adjunct Senior Lecturer at the Department of Oncology-Pathology, Karolinska Institute, specializing in breast cancer research and cardio-oncology. She actively contributes to translational studies focusing on treatment-related cardiovascular toxicity, BRCA1/2 mutations, and survivorship outcomes.

• Academic Rank: Senior Lecturer
• Department: Oncology-Pathology
• Institution: Karolinska Institute, Stockholm

Her research spans:

• Breast Cancer Subtype-Specific Survival
• Cardio-Oncology (chemotherapy-induced cardiotoxicity, heart disease risk)
• Germline BRCA Status and Outcomes
• Cancer Survivorship (return to work, sickness benefits)
• Tumor Microenvironment (GATA-3, M2 macrophages)
• Clinical Decision-Making (4D PICTURE project)

Recent publications highlight her work in:

• Cardiovascular complications in cancer patients
• HER2-positive breast cancer survival benchmarks
• BRCA mutations and cardiovascular health
• Longitudinal analysis of treatment toxicity
• Patient-centered quality of life metrics
• Epidemiological studies on venous thromboembolism